Arete Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-8,594
| Closed | -$388K | – | 404 |
|
|
2025
Q3 | $388K | Sell |
8,594
-1,269
| -13% | -$59.3K | 0.02% | 514 |
|
|
2025
Q2 | $457K | Buy |
9,863
+396
| +4% | +$19.4K | 0.03% | 434 |
|
|
2025
Q1 | $577K | Buy |
9,467
+1,721
| +22% | +$100K | 0.04% | 349 |
|
|
2024
Q4 | $438K | Buy |
7,746
+2,247
| +41% | +$126K | 0.03% | 447 |
|
|
2024
Q3 | $284K | Sell |
5,499
-3,289
| -37% | -$154K | 0.02% | 539 |
|
|
2024
Q2 | $365K | Sell |
8,788
-3,766
| -30% | -$169K | 0.03% | 482 |
|
|
2024
Q1 | $679K | Sell |
12,554
-480
| -4% | -$24.5K | 0.06% | 268 |
|
|
2023
Q4 | $669K | Buy |
13,034
+435
| +3% | +$22.8K | 0.05% | 335 |
|
|
2023
Q3 | $731K | Sell |
12,599
-10,199
| -45% | -$625K | 0.13% | 177 |
|
|
2023
Q2 | $1.46M | Sell |
22,798
-6,555
| -22% | -$440K | 0.13% | 163 |
|
|
2023
Q1 | $2.03M | Buy |
29,353
+1,791
| +6% | +$126K | 0.17% | 119 |
|
|
2022
Q4 | $1.98M | Buy |
27,562
+3,923
| +17% | +$296K | 0.17% | 115 |
|
|
2022
Q3 | $1.68M | Buy |
23,639
+8,871
| +60% | +$644K | 0.16% | 118 |
|
|
2022
Q2 | $1.14M | Sell |
14,768
-775
| -5% | -$59K | 0.12% | 133 |
|
|
2022
Q1 | $1.14M | Buy |
15,543
+429
| +3% | +$28.8K | 0.1% | 166 |
|
|
2021
Q4 | $936K | Buy |
15,114
+604
| +4% | +$35.4K | 0.08% | 198 |
|
|
2021
Q3 | $859K | Buy |
14,510
+53
| +0.4% | +$3.49K | 0.09% | 181 |
|
|
2021
Q2 | $886K | Buy |
14,457
+35
| +0.2% | +$2.28K | 0.12% | 147 |
|
|
2021
Q1 | $910K | Buy |
14,422
+1,456
| +11% | +$90.6K | 0.12% | 172 |
|
|
2020
Q4 | $803K | Buy |
12,966
+1,211
| +10% | +$74.5K | 0.11% | 172 |
|
|
2020
Q3 | $691K | Buy |
11,755
+423
| +4% | +$25.5K | 0.1% | 184 |
|
|
2020
Q2 | $666K | Sell |
11,332
-1,491
| -12% | -$89.2K | 0.12% | 189 |
|
|
2020
Q1 | $715K | Buy |
12,823
+307
| +2% | +$18.8K | 0.14% | 157 |
|
|
2019
Q4 | $803K | Sell |
12,516
-3,570
| -22% | -$204K | 0.14% | 174 |
|
|
2019
Q3 | $816K | Buy |
16,086
+1,666
| +12% | +$78.3K | 0.16% | 161 |
|
|
2019
Q2 | $654K | Buy |
14,420
+5,102
| +55% | +$238K | 0.13% | 183 |
|
|
2019
Q1 | $445K | Sell |
9,318
-4,658
| -33% | -$232K | 0.09% | 225 |
|
|
2018
Q4 | $726K | Sell |
13,976
-6,182
| -31% | -$332K | 0.18% | 142 |
|
|
2018
Q3 | $1.25M | Sell |
20,158
-53
| -0.3% | -$3.15K | 0.28% | 83 |
|
|
2018
Q2 | $1.12M | Buy |
20,211
+7,383
| +58% | +$399K | 0.27% | 91 |
|
|
2018
Q1 | $811K | Buy |
12,828
+1,703
| +15% | +$110K | 0.27% | 100 |
|
|
2017
Q4 | $682K | Buy |
11,125
+746
| +7% | +$46.7K | 0.22% | 126 |
|
|
2017
Q3 | $662K | Buy |
10,379
+1,597
| +18% | +$93.2K | 0.26% | 120 |
|
|
2017
Q2 | $489K | Buy |
+8,782
| New | +$478K | 0.22% | 125 |
|
|
2016
Q1 | – | Sell |
-3,028
| Closed | -$208K | – | 147 |
|
|
2015
Q4 | $208K | Buy |
+3,028
| New | +$200K | 0.13% | 117 |
|
Other funds holding BMY
Arete Wealth Advisors's BMY Position: Q4 2025 in Review
Arete Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 8,594 shares — an estimated $388K sold.
Arete Wealth Advisors first reported a position in BMY in Q4 2015 and held it in 35 quarters. The position peaked at $2.03M in Q1 2023. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Arete Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Arete Wealth Advisors sold 8,594 Bristol-Myers Squibb shares in Q4 2025, an estimated $388K.
- Arete Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 35 quarters.
- Arete Wealth Advisors's Bristol-Myers Squibb position peaked at $2.03M in Q1 2023.
- 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Arete Wealth Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.